Development of an Enzyme-Linked Immunosorbent Assay Method for Residual Host Cell derived Proteins in Recombinant Antibody Drug Production
![]() |
Joung, Chan-Hi
(Department of Biological Engineering, Inha University)
Lim, Sang-Min (Department of Biological Engineering, Inha University) Koo, Yoon-Mo (Department of Biological Engineering, Inha University) Lee, Yong-Yoon (ISU ABXIS Co. Ltd.) Son, Young-Su (ISU ABXIS Co. Ltd.) Kim, Hyun-Il (ISU ABXIS Co. Ltd.) Park, Heung-Rok (ISU ABXIS Co. Ltd.) |
1 | Briggs, J., V. T. Kung, B. Gomez, K. C. Kasper, P. A. Nagainis, R. S. Masino, L. S. Rice, R. F. Zuk and V. E. Ghazarossian (1990), Sub-femtomole quantitation of proteins with Threshold for the biophamaceutical industry, Biotechniques 9, 598-606 |
2 | Robey, F. A.(1986), In Methods in Protein Sequence Analysis, K. A. Walsh Eds.: Human Press, Clifton, NJ, pp67-78 |
3 | Anicetti, V. R., E. F. Fehskens, B. R. Reed, A. B. Chen, P. Moore, M. D. Geier and A. J. Jones (1986), Immunoassay for the detection of E. coli proteins in recombinant DNA derived human growth hormone, J. Immunol. Methods 91, 213-224 DOI ScienceOn |
4 | Eaton, L. C. (1995), Host cell contaminant protein assay development for recombinant biopharmaceuticals, J. Chromatogr. A 705, 105-114 DOI ScienceOn |
5 | Garg, V. K., M. A. Costello, and B. A. Czuba (1991), Purification and production of therapeutic grade proteins, Bioprocess Technol. 12, 29-54 |
6 | Nicholson, I. C., X. Zou, A. V. Popov, G. P. Cook, E. M. Corps, S. Humphries, C. Ayling, B. Goyenechea, J. Xian, M. J. Taussig, M. S. Neuberger and M. Bruggemann (1999), Antibody repertoires of four- and five-feature translicus mice carrying human immunoglobulin heavy chain and kappa and lambda light chain yeast artificial chromosomes, J. Immunol. 163, 6898-6906 |
7 | Jones, A. J. and J. V. O'Connor (1985), Control of recombinant DNA produced pharmaceuticals by a combination of process validation and final product specifications, Dev. Biol. Stand. 59, 175-180 |
8 | Himanen, J. P., M. Sarvas and I. M. Helander (1993), Assessment of non-protein impurities in potential vaccine proteins produced by Bacillus subtilis, Vaccine 11, 970-973 DOI ScienceOn |
9 | Kung, V. T., P. R. Panfili, E. L. Sheldon, R. S. King, P. A. Nagainis, B. Gomez, D. A. Ross, J. Briggs and R. F. Zuk (1990), Picogram quantitation of total DNA using DNA-binding proteins in a silicon sensor-based system, Anal. Biochem. 187, 220-227 DOI ScienceOn |
10 | Bass, R. (1996), ICH Topic Q 2 B Validation of Analytical Procedures; Methodology, Step 4 Consensus Guidline 6, ICH-Technical Coordination |
11 | Eaton, L. C. (1989), Quantitation of residual Escherichia coli DNA in recombinant biopharmaceutical proteins by hybridization analysis, J. Pharm. Biomed. Anal. 7, 633-638 DOI ScienceOn |
12 | Anicetti, V. R. (1990), Analytical Biotechnology: Capillary Electrophoresis and Chromatography, In ACS Symposium Series, Cs. Horvath and J. G. Nikelly Eds: American Chemical Society, Washington DC. No. 434, 127-140 |
13 | Anicetti, V. R., B. A. Keyt and W. S. Hancock (1989), Purity analysis of protein pharmaceuticals produced by recombinant DNA technology, Trends. Biotechnol. 7, 342-349 DOI ScienceOn |
14 | Lucas, C., C. Nelson, M. L. Peterson, S. Fire, D. Vetterlein, T. Gregory and A. B. Chen (1998), Enzyme-linked immunosorbent assays (ELISAs) for the determination of contaminants resulting from the immunoaffinity purification of recombinant proteins, J. Immunol. Methods 113, 113-122 DOI ScienceOn |
![]() |